Table 2.

Impact of diabetes on all-cause death according to treatment strategies

	Diabetes (n = 452)	No diabetes (n = 1348)	P  -value	Unadjusted HR (95% CI)	Unadjusted P-value	Adjusted HR (95% CI)	Adjusted P-value
10 years
Overall	35.4% (152)	23.6% (308)	<0.001	1.61(1.32–1.95)	<0.001	1.58(1.27–1.95)	<0.001
PCI	36.4% (80)	25.8% (168)	0.002	1.53(1.17–2.00)	0.002	1.54(1.15–2.06)	0.003
CABG	34.5% (72)	21.4% (140)	<0.001	1.70(1.28–2.26)	<0.001	1.65(1.19–2.28)	0.003
Maximum follow-up
Overall	60.7% (187)	35.4% (381)	<0.001	1.66(1.40–1.98)	<0.001	1.67(1.38–2.02)	<0.001
PCI	51.2% (94)	37.5% (209)	0.001	1.49(1.16–1.89)	0.001	1.55(1.19–2.01)	0.001
CABG	67.0% (93)	32.2% (172)	<0.001	1.88(1.46–2.42)	<0.001	1.85(1.38–2.47)	<0.001

Percentage of deaths at a given time point, based on Kaplan–Meier estimates (number of deaths). The number of patients entered into the multivariable Cox model was 87.2% (1570/1800) patients in the overall population, 90.0% (813/903) patients in the PCI arm, and 84.4% (757/897) patients in the CABG arm.

CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention.